Home > Financial Ratios > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
Core EBITDA Margin

    Back to All Ratios
PAR DRUGS AND CHEMICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

PAR DRUGS AND CHEMICALS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 16.8119.1623.1814.8615.49

What is the latest Core EBITDA Margin ratio of PAR DRUGS AND CHEMICALS ?

The latest Core EBITDA Margin ratio of PAR DRUGS AND CHEMICALS is 16.81 based on Mar2023 Standalone results.
Year Core EBITDA Margin
Mar202316.81
Mar202219.16
Mar202123.18
Mar202014.86
Mar201915.49

How is Core EBITDA Margin of PAR DRUGS AND CHEMICALS Trending?

Years Core EBITDA Margin % Change
Mar2023 16.81
-12.27
Mar2022 19.16
-17.34
Mar2021 23.18
55.99
Mar2020 14.86
-4.07
Mar2019 15.49 -

Other Financial Ratios of PAR DRUGS AND CHEMICALS


Compare Core EBITDA Margin ratio of peers of PAR DRUGS AND CHEMICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS ₹308.2 Cr -2.7% 1.5% 49.4% Stock Analytics
PIDILITE INDUSTRIES ₹151,723.0 Cr 5.9% -0.5% 18% Stock Analytics
SOLAR INDUSTRIES INDIA ₹77,868.0 Cr -1% -0.4% 133.5% Stock Analytics
SRF ₹67,762.7 Cr -2.3% -13.6% -13.4% Stock Analytics
GUJARAT FLUOROCHEMICALS ₹35,773.8 Cr -1.6% -6.3% -2% Stock Analytics
DEEPAK NITRITE ₹33,637.9 Cr -1.5% 7.4% 26.9% Stock Analytics


PAR DRUGS AND CHEMICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS

-2.7%

1.5%

49.4%

SENSEX

-0.6%

-2.1%

18.4%


You may also like the below Video Courses